ProfileGDS4718 / 51228_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 47% 49% 59% 48% 58% 66% 63% 48% 48% 50% 53% 53% 62% 71% 57% 50% 61% 61% 61% 58% 41% 54% 53% 54% 49% 64% 54% 67% 53% 63% 58% 61% 53% 48% 65% 67% 64% 53% 50% 62% 56% 65% 62% 68% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3641147
GSM549102patient 115, normal, homogenized [OPG study]5.4842549
GSM549104patient 119, normal, homogenized [OPG study]6.0605259
GSM549108patient 138, normal, homogenized [OPG study]5.4704648
GSM549119patient 077, normal, homogenized [OPG study]5.970258
GSM549133patient 032, cancer, homogenized [OPG study]6.5575666
GSM549139patient 042, cancer, homogenized [OPG study]6.3184263
GSM549099patient 107, normal, homogenized [OPG study]5.4194648
GSM549109patient 139, normal, homogenized [OPG study]5.4282448
GSM549110patient 046, normal, homogenized [OPG study]5.490150
GSM549114patient 063, normal, homogenized [OPG study]5.6306253
GSM549122patient 082, normal, homogenized [OPG study]5.7244653
GSM549134patient 033, cancer, homogenized [OPG study]6.2631662
GSM549136patient 036, cancer, homogenized [OPG study]6.9867471
GSM549140patient 044, cancer, homogenized [OPG study]5.912957
GSM549111patient 047, normal, homogenized [OPG study]5.4802350
GSM549113patient 057, normal, homogenized [OPG study]6.1502261
GSM549132patient 031, cancer, homogenized [OPG study]6.1999861
GSM549137patient 038, cancer, homogenized [OPG study]6.1932361
GSM549142patient 047, cancer, homogenized [OPG study]6.1029658
GSM549100patient 110, normal, homogenized [OPG study]5.089641
GSM549107patient 135, normal, homogenized [OPG study]5.7502554
GSM549115patient 068, normal, homogenized [OPG study]5.6621153
GSM549116patient 072, normal, homogenized [OPG study]5.741654
GSM549120patient 078, normal, homogenized [OPG study]5.4502449
GSM549131patient 030, cancer, homogenized [OPG study]6.4203964
GSM549118patient 074, normal, homogenized [OPG study]5.7383854
GSM549129patient 027, cancer, homogenized [OPG study]6.6818267
GSM549123patient 088, normal, homogenized [OPG study]5.6788153
GSM549124patient 006, cancer, homogenized [OPG study]6.3476863
GSM549126patient 015, cancer, homogenized [OPG study]6.0124658
GSM549128patient 025, cancer, homogenized [OPG study]6.2438161
GSM549103patient 117, normal, homogenized [OPG study]5.7263653
GSM549117patient 073, normal, homogenized [OPG study]5.3835848
GSM549138patient 041, cancer, homogenized [OPG study]6.5274265
GSM549141patient 045, cancer, homogenized [OPG study]6.6848367
GSM549130patient 028, cancer, homogenized [OPG study]6.377364
GSM549101patient 111, normal, homogenized [OPG study]5.6893253
GSM549105patient 128, normal, homogenized [OPG study]5.5532250
GSM549106patient 134, normal, homogenized [OPG study]6.2736362
GSM549112patient 048, normal, homogenized [OPG study]5.8781556
GSM549125patient 011, cancer, homogenized [OPG study]6.4961665
GSM549127patient 024, cancer, homogenized [OPG study]6.3213462
GSM549135patient 035, cancer, homogenized [OPG study]6.7826468